Qura’s service targets patients with persistent subclinical symptoms that fall below the threshold of acute illness but can substantially affect quality of life.
Italian-founded AI preventative health platform Qura has raised €1.5m in a pre-seed funding round led by United Ventures.
The investment is earmarked for team expansion and product development as the company builds out its platform targeting patients with persistent subclinical symptoms that fall below the threshold of acute illness but can substantially affect quality of life.
The funding round also included support from Vento and Italian Angels for Growth, alongside a number of individual angel investors.
The company said “a significant gap in the European healthcare landscape” means that one in five adults live with untreated issues such as chronic fatigue, hormonal imbalances, digestive problems or unexplained hair loss because traditional primary care systems are not designed to manage such conditions effectively or to support people before symptoms become diagnoses.
“We treat health like an emergency instead of a priority,” said Virginia Gambardella, CEO and co-founder of Qura. “Millions of people know something is off, but the current system doesn’t give them the tools or the guidance to act. Qura changes that – we combine the precision of AI with the trust of a real doctor to help people stay well, not just get better.”
Qura users undergo blood testing at a partner laboratory, followed by AI-driven analysis and a 45-minute consultation with a physician. The patient then receives “a personalised health protocol with clear priorities – what to act on immediately and what to monitor over time – supported by continuous follow-up and medical guidance”, according to the company.
According to research from Grand View Horizon, the European health check-up market is set to grow to approximately €18.6bn by 2030. Meanwhile, Eurostat figures show that EU countries collectively spent €90.4bn on preventative health care in 2022, yet traditional Italian and European healthcare systems remain geared towards treatment of emergencies and acute conditions, according to Qura.
The company said its hybrid care model keeps doctors at the centre of the process “while AI enhances efficiency and personalisation – an approach designed to build trust, drive adherence, and raise quality of care”.
Proceeds from the funding round will be allocated to hiring across medical, engineering and operations functions; investing in digital marketing and community-driven growth; advancing Qura’s AI health intelligence capabilities; and preparing for expansion into additional European markets.
In terms of infrastructure, Qura said it is conscious of regulatory alignment in building “an EU-native platform that is GDPR-compliant, medically validated and fully integrated with local laboratory networks”.
Qura was founded in 2025 by Gambardella and Gioacchino Grand, who is also the company’s CTO. United Ventures is a Milan-based venture capital firm founded in 2012.
Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.
